Reuters logo
3 个月前
BRIEF-Acerus announces Natesto license agreement with Therios Healthcare
2017年6月5日 / 中午11点42分 / 3 个月前

BRIEF-Acerus announces Natesto license agreement with Therios Healthcare

June 5 (Reuters) - Acerus Pharmaceuticals Corporation

* Acerus announces NATESTO license agreement with Therios Healthcare

* Acerus Pharmaceuticals - signing of agreement granting exclusive right to market NATESTO in Saudi Arabia, UAE and Egypt to Therios Healthcare

* Acerus Pharmaceuticals - under terms of license & supply agreement, co will oversee manufacturing of NATESTO and receive a supply price for product

* Acerus Pharmaceuticals - if regulatory approval is obtained, NATESTO could potentially be available in Saudi Arabia as soon as first half of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below